Filing Flows › Quanex Building Products (NX) › Stock forecast & fair value
Quanex Building Products (NX) stock forecast and fair value
Quanex Building Products (NX) trades at $20.70. 4 analysts' median price target is $25.50 (+23%), from $23.00 to $30.00. Across 16 valuation methods the middle fair value is $21.52 (+4%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $8.85 | $18.33 | $23.75 | -11% |
| P/E vs peers, weighted | $16.28 | $23.83 | $50.54 | +15% |
| P/E vs peers, matched | $8.85 | $18.33 | $23.75 | -11% |
| EV/EBITDA vs peers | $28.37 | $46.56 | $91.58 | +125% |
| EV/EBITDA vs peers, weighted | $37.39 | $77.29 | $106.35 | +273% |
| EV/EBITDA vs peers, matched | $28.37 | $46.56 | $91.58 | +125% |
| Residual income | $13.26 | $13.74 | $14.24 | -34% |
| Analysts' price targets | $23.00 | $26.00 | $30.00 | +26% |
| Owner earnings capitalized | $21.82 | $24.48 | $27.89 | +18% |
| Shareholder yield (dividends + buybacks) | $11.54 | $12.95 | $14.75 | -37% |
Quanex Building Products' latest quarter
Quanex Building Products, Q3 FY26: revenue $502M (+1% year over year), operating margin 9.3%, net earnings $26.5M, operating cash flow $58.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NX stock?
The median of 4 analysts' 12-month targets is $25.50, +23% from $20.70; the range is $23.00 to $30.00. The average rating is none.
What is Quanex Building Products' fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $4.40 and $77.29, with a middle value of $21.52 against a price of $20.70. Each method's assumptions are on the page.
Does Quanex Building Products usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is NX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.